Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Fanelli C et al. | 1999 | intact cell/cell culture, CEM cells (human acute lymphoblastic leukemia), U937 (human leukemic monocyte cell line), leucocytes, rat thymocytes | static magnetic field | 6 mT |
Hirano M et al. | 1998 | bacterium, <i>Spirulina platensis</i> | static magnetic field | - |
Yan QC et al. | 1998 | animal, rat/Wistar, partial body: femur | static magnetic field | 180 mT |
Blackman CF et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, low frequency, DC, static magnetic field | 23.8–36.6 µT |
Nakamura K et al. | 1997 | bacterium, <i>Bacillus subtilis</i>/MI13 (normal or transformed with plasmid pC112 to enable the synthesis of surfactin (a cyclic lipopeptide antibiotic)) | static magnetic field, DC | 5.2–7 T |
Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Reipert BM et al. | 1996 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2–65 µT |
Raylman RR et al. | 1996 | intact cell/cell culture, HTB 63 (melanoma cells), HTB 77 IP3 (ovarian carcinoma cells) and CCL 86 (lymphoma cells) | static magnetic field | 7 T |
Tanioka N et al. | 1996 | intact cell/cell culture, B16C2 (murine melanoma cells) and EL-4 (murine T-lymphoma cells) | static magnetic field, MRI | 6.34 T |
Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.